This action might not be possible to undo. Are you sure you want to continue?

BooksAudiobooksComicsSheet Music### Categories

### Categories

### Categories

### Publishers

Scribd Selects Books

Hand-picked favorites from

our editors

our editors

Scribd Selects Audiobooks

Hand-picked favorites from

our editors

our editors

Scribd Selects Comics

Hand-picked favorites from

our editors

our editors

Scribd Selects Sheet Music

Hand-picked favorites from

our editors

our editors

Top Books

What's trending, bestsellers,

award-winners & more

award-winners & more

Top Audiobooks

What's trending, bestsellers,

award-winners & more

award-winners & more

Top Comics

What's trending, bestsellers,

award-winners & more

award-winners & more

Top Sheet Music

What's trending, bestsellers,

award-winners & more

award-winners & more

P. 1

Estimating Inputs for Valuation|Views: 8|Likes: 0

Publicado porAvinash Kharde

See more

See less

https://pt.scribd.com/doc/44829574/Estimating-Inputs-for-Valuation

07/11/2013

text

original

Errors in estimating the discount rate or mismatching cashflows and discount rates can lead to serious errors in valuation. * At an intutive level, the discount rate used should be consistent with both the riskiness and the type of cashflow being discounted. I. Cost of Equity The cost of equity is the rate of return that investors require to make an equity investment in a firm. There are two approaches to estimating the cost of equity; * a risk and return model * a dividend-growth model. Models of Risk and Return The Capital Asset Pricing Model * Measures risk in terms on non-diversifiable variance * Relates expected returns to this risk measure. * It is based upon several assumptions (a) that investors have homogeneous expectations about asset returns and variances (b) that they can borrow and lend at a riskfree rate (c) that all assets are marketable and perfectly divisible (d) that there are no transactions costs and that there are no restrictions on short sales. Risk in the CAPM Beta: The non-diversifiable risk for any asset can be measured by the covariance of its returns with returns on a market index, which is defined to be the asset's beta. The cost of equity will be the required return, Cost of Equity = Rf + Equity Beta * (E(Rm) - Rf) where,

Rf = Riskfree rate E(Rm) = Expected Return on the Market Index Using the Capital Asset Pricing Model * Inputs required to use the CAPM (a) the current risk-free rate (b) the expected return on the market index and (c) the beta of the asset being analyzed. Practical issues in using the CAPM -1. Measurement of the risk premium * It is generally based upon historical data, and the premium is defined to be the difference between average returns on stocks and average returns on riskfree securities over the measurement period. Magnitude of the risk premium Historical Period 1926-1990 1962-1990 1981-1990 Stocks - T. Bills Arithmetic 8.41% 4.10% 6.05% Geometric 6.41% 2.95% 5.38% Stocks - T.Bonds Arithmetic 7.24% 3.92% 0.13% Geometric 5.50% 3.25% 0.19%

*** Generally, geometric averages provide better estimates of risk premiums in valuation.
**

y

The risk premiums will vary across markets, depending upon their riskiness. While historical data can be used to estimate premiums outside the United States, it is not very reliable. An alternative way of estimating premiums is to use country bond ratings to estimate these premiums relative to the U.S. premium. For instance, the risk premiums for South American countries can be estimated as follows: Rating BBB BB Risk Premium 5.5% + 1.75% = 7.25% 5.5% + 2% = 7.5%

Country Argentina Brazil

00% + 1.. Wellcome has a beta of 0. At the same point in time. Which beta would you use in valuing Glaxo? .25% 5. Illustration 3: Using the CAPM to calculate cost of equity Glaxo Holdings had an estimated beta of 1. it may make sense to look at the rate at which large corporations can borrow in the local market.50% + 1.50%) = 14.10 (5.05% This is the cost of equity.5% + 1.1% A Warning: If you add a default premium to the risk premium.00%. y Wellcome is planning an acquisition of Glaxo.65.6% = 7.75% 5.55% This difference reflects differences in expected inflation in the two markets.75% = 6.25% = 6. The same estimation can be done in British Pounds.10 (5. That would be double counting. using the long term Government Bond rate in the U.5% = 7% 5.10 at the end of 1994. The estimated cost of equity for Glaxo in December 1994 was ñ Cost of Equity = 8. which was 8. When the long term government bond rate is not available. the thirty-year treasury bond rate in the United States was 8.5% + 2.K.Chile Columbia Mexico Paraguay Peru Uruguay AA A+ BBB+ BBBB BBB 5. do not add a risk premium to the risk free rate.5% = 8% 5.50% at the same point in time ñ Cost of Equity (British Pounds) = 8. if cash flows are estimated in dollars.5% + 1.5% + 0.75% = 7.25% 5. Riskfree Rate The long-term government bond rate is the appropriate riskfree rate.5% + 1.50%) = 14.5% + 1. II.

y Pharmaceutical companies are increasingly looking at expanding into biotechnology. had a beta of 1. (Synergen. Levered Beta = Unlevered Beta (1 + (1-t) (D/E)) . * The beta of a firm is the weighted average of the betas of its different business lines. * A firm which has high operating leverage -> higher variability in earnings before interest and taxes (EBIT) -> higher beta y Sticking again with pharmaceutical firms. there are some firms which have very high fixed costs. It had research and development expenses which were 670% of sales in 1994. and is usually defined in terms of the relationship between fixed costs and total costs.) These firms will have higher betas than other firms which have more traditional cost structures. Degree of Operating Leverage: * DOL is a function of the cost structure of a firm. i. Thus cyclical firms can be expected to have higher betas. than non-cyclical firms. the higher is its beta. either through acquisitions or through projects.65 in 1994. the beta of debt is zero.Determinants of Betas I. What would the impact of these actions be on pharmaceutical firmsí betas? II.. for instance. (Wellcome is a good example. Biotechnology firms have an average beta of 1. and debt has a tax benefit to the firm.) III. or because of the nature of their business. Type of Business: * The more sensitive a business is to market conditions. Financial Leverage: * An increase in financial leverage will increase the equity beta of a firm.8. * If all of the firm's risk are borne by the stockholders. then.e. other things remaining equal. either because they focus heavily on research.

07 (1+0.97 Debt/Equity 0. The private firm had a debt/equity ratio of 30%.20 0.07 New Levered Beta = 1.17 .10 /(1+0.80 0.05 0.90 1.10. t = Corporate tax rate D/E = Debt/Equity Ratio Illustration 4: Effects of Financial Leverage on Betas Glaxo.7*0. its beta would be much higher (Tax rate was 30%) ñ Current Beta (Levered) = 1. The betas of publicly traded firms involved in office equipment and supplies are as follows (They face an average tax rate of 40%).95 0.10 Unlevered Beta = 1. had a debt/equity ratio of 4% in 1994.where. selling and servicing fax machines. Using comparable firms: * Use the betas of publicly traded firms which are comparable in terms of business risk and operating leverage. * Correct for differences in financial leverage between the firm being analyzed and the comparable firms.04) = 1. Illustration 5: Using comparable firms to estimate betas Assume that you are trying to estimate the beta for a private firm that is in the business of manufacturing.7*0. with a beta of 1. If Glaxo were to raise its debt/equity ratio to 20%.10 0.45 1.00 0.03 0. Firm General Binding Hunt Manufacturing Moore Coroporation Nashua Company Pitney Bowes Average Beta 1.2) = 1.20 0.22 Other approaches to estimating Betas I.

15 Debt/Equity Ratio + 0.000 (in thousands) The estimated beta for this firm. Using fundamental factors: * Combines industry and company-fundamental factors to predict betas.9832 + 0.2 Dividend Yield = 0. * Income statement and balance sheet variables are important predictors of beta * Following is a regression relating the betas of NYSE and AMEX stocks in 1991 to five variables . CV in Operating Income = Coefficient of Variation in Operating Income = Standard Deviation in Operating Income/ Average Operating Income Illustration 6: Using fundamental information to predict betas Assume that you are trying to estimate the beta for a private firm.04 Debt/Equity Ratio = 0.4) (0.0. coefficient of variation in operating income. with the following financial characteristics (defined consistently with the regression): Coefficient of Variation in Operating Income = 2.00001 Total Assets where.88 Beta for private firm involved in office supplies = 0.88 (1 + (1-0.08 CV in Operating Income .97 / (1 + (1-0.034 Growth in Earnings per Share .30 Growth in Earnings per share = 0. size.17)) = 0.04 II. debt/equity and growth in earnings.126 Dividend Yield + 0.30 Total Assets = $ 10. .dividend yield.0.Unlevered Beta of office supply firms = 0.3)) = 1. BETA = 0.4) (0.

0.35% E(R1) . is not a single factor but is determined by an asset's sensitivity to various economic factors that affect all assets. * The number and the identity of the factors are determined by the data on historical returns. and that there are three factors..5% : Risk Premium for factor 3 Assume that the betas specific to each of these factors are estimated for Pepsi Cola in 1992 and . Riskfree rate = 3.034 * 0. however.9832 +0.04 + 0.000 = 1.Rf = Risk premium per unit of factor j risk k = Number of factors Using the Arbitrage Pricing Model Illustration 7: Using the APM to estimate the cost of equity Assume that the parameters for the arbitrage pricing model have been estimated. investors get rewarded for taking on non-diversifiable risk.e. i.BETA = 0.15* 0. Rf = Riskfree rate Fj = Beta specific to factor j E(Rj) .Rf = 1. the cost of equity can also be estimated.Rf = 4% : Risk Premium for factor 2 E(R3) . where. * The arbitrage pricing model relates expected returns to economic factors. If these factor-specific betas and the factor risk premia can be estimated.19 The Arbitrage Pricing Model * Logic behind the arbitrage pricing model (APM) same as the logic behind the CAPM.08*2.30 + 0. * Measure of this non-diversifiable risk in the APM.2 . with a beta specific to each factor.126* 0.30 .Rf = 3% : Risk Premium for factor 1 E(R2) .00001*10.0.

Example: Oil companies. Multi-factor Models for risk and return * Unidentified factors in the arbitrage pricing model are replaced with macro-economic variables. which derive most of their risk from oil price movements.industrial production. with firm-specific betas calculated relative to each variable. * Costs of going from the arbitrage pricing model to a macro-economic multi-factor model can be traced directly to the errors that can be made in identifying the factors. * For example. * The factors in the model can change over time. . These variables can then be correlated with returns to come up with a model of expected returns. shifts in the term structure. the CAPM has the advantage of being a simpler model to estimate and to use.that the estimates are as follows: F1 = 1. as will the risk premia associated with each economic factor. but it will underperform the richer APM when the company is sensitive to economic factors not well represented in the market index. * The biggest intuitive block in using the arbitrage pricing model is its failure to identify specifically the factors driving expected returns.5%) = 12. unanticipated inflation and changes in the real rate of return.35% + 1. changes in default premium.20 (3%) + 0.90 (4%) + 1. * In general.20% Considerations on the use of the APM * Capital asset pricing model can be considered to be a specialized case of the arbitrage pricing model. Chen.90 F3 = 1.20 F2 = 0. tend to have low CAPM betas. where there is only one underlying factor and that underlying factor is completely measured by the market index. Roll and Ross (1986) suggest that the following macroeconomic variables are highly correlated with the factors that come out of factor analysis -.1 (1. Cost of Equity = 3.10 Substituting into the APM.

98 Cost of Equity = $2.* Using the wrong factor(s) or missing a significant factor in a multi-factor model can lead to inferior estimates of cost of equity. Illustration 8: Using the Dividend Growth Model to estimate the cost of equity: Southwestern Bell In 1992. There is a strong element of circular reasoning involved that will lead the analyst to conclude.82 and the stock traded at $66 in December 1992. Dividend Growth Model For a firm which has a stable growth rate in earnings and dividends. the present value of a share of equity can be written as: Po = Present Value of expected dividends = DPS1 / (ke . Expected Dividends in 1993 = $2. it is inappropriate to use this approach to value stock in a firm.98 / $66 + 5.5% and the firm is assumed to be in steady state. ke = DPS1 / P0 + g = Expected Dividend Yield + Growth rate in earnings/dividends More importantly. using this cost of equity. that equity is fairly valued. P0 = Price of the stock today DPS1 = Expected dividends per share next year ke = Cost of Equity g = Growth rate in dividends (steady state) A simple manipulation of this formula yields. The dividend growth model can then be used to estimate the cost of equity. The estimated growth rate in dividends is 5.5% . since the current price is a key input to the model. Southwestern Bell paid dividend per share of $2.82 *1.g) where.055 = $2.

(Pre-tax cost of debt=9.10 .= 10% To illustrate the circular reasoning involved in using this cost of equity to value stock.. .80% * an after-tax cost of debt of 6. Genzyme Corporation had * a beta of 1. In December 1994. Tax rate=30%) * Equity comprised 85. This results in Cost of equity = 8.60 (5.98 / (.00%.00%+1. Value of Equity = $ 2.00% (in market value terms) of the funding mix and debt made up the remaining 15.60.30%. Weighted Average Cost of Capital (WACC) Definition of the Weighted Average Cost of Capital (WACC) The weighted average cost of capital is defined as the weighted average of the costs of the different components of financing used by a firm.055) = $66 Not surprisingly. WACC = Weighted Average Cost of Capital ke = Cost of Equity kd = After-tax Cost of Debt kps = Cost of Preferred Stock E/(E+D+PS) = Market Value proportion of Equity in Funding Mix D/(E+D+PS) = Market Value proportion of Debt in Funding Mix PS/(E+D+PS) = Market Value proportion of Preferred Stock in Funding Mix Illustration 9: Calculating the Cost of Capital: Genzyme Corporation.00%. WACC = ke ( E/ (D+E+PS)) + kd ( D/ (D+E+PS)) + kps ( PS/ (D+E+PS)) where. the stock is found to be fairly valued.50%) = 16.

Capital Expenditures .Working Capital Needs .15) = 15.85) + 6.* The cost of capital for Genzyme can then be calculated as follows: WACC = 16.Principal Repayments + Proceeds from New Debt Issues = Free Cash flow to Equity Levered Firm at Desired Leverage Net Income .Taxes = Net Income + Depreciation & Amortization = Cash flows from Operations .Preferred Dividends . taxes and depreciation (EBITDA) .80% (0.Depreciation & Amortization = Earnings before interest and taxes (EBIT) .Interest Expenses = Earnings before taxes .23 % ESTIMATION OF CASH FLOWS Cash flows to Equity for a Levered Firm Revenues .30% (0.Operating Expenses = Earnings before interest.

52 $ 18. and sales are expected to increase from $6420 million in 1994 to $7100 million in 1995. The company reported depreciation of $180 million in 1994 and is expected to have depreciation of $200 million in 1995.50 14%) $ 572.00 Net Income .. Thus FCFE will be an increasing function of _. 1994 $ 695.Depreciation) (1-DR) .5 billion in debt outstanding and $ 9 billion in market value of equity. The company had capital expenditures of $362 million in 1994 and is expected to have capital expenditures of $400 million in 1995. Proceeds from new debt issues = Principal Repayments +DR (Capital Expenditures Depreciation + Working Capital Needs) Illustration 10: Estimating the cash flow to equity for a firm at its desired leverage: WarnerLambert The following is an estimation of free cash flows to equity for Warner-Lambert in 1994 and for 1995 (projected). (How does one know?) The company reported net income of $695 million in 1994 and is projected to have a net income of $765 million in 1995.(Cap Ex .00 (DR = 14%) (DR = $ 20.(1.DR) (Capital Expenditures .50 $ 172.( Change in Working Capital) (1-DR) FCFE Proposition : The Free Cash Flow to Equity will increase as the amount of debt financing used by the firm increases.(1. This debt ratio is assumed to be stable.00 $ 156. The companyís working capital increased to $225 million in 1994 from $203 million in 1993. .Depreciation) . It is expected to maintain working capital at the same percentage of sales in 1995.92 $ 519.DR) Working Capital Needs = Free Cash flow to Equity For this firm. y y y y y The company had $1. leading to a debt to capital ratio (ìdebt ratioî) of 14%.56 Estd 1995 $ 765.

Warner Lambert Corporation The following are the cash flows to equity for Warner Lambert.00 .Depreciation) (DR = $ 109.(Cap Ex .Illustration 11: Sensitivity to Debt Ratio .Change in Working Capital .Capital Spending .60 $ 630.70 The following graph illustrates the effect on free cash flows to equity of changing the debt ratios from 0% to 100% ñ CASHFLOWS TO THE FIRM EBIT ( 1 .00 $ 765. 1994 Estd 1995 Net Income $ 695.00 (1-DR) 40%) .30 Capital) (1-DR) 40%) FCFE $ 572. using a debt ratio of 40% instead of a debt ratio of 14%.( Change in Working (DR = $ 13.tax rate) + Depreciation .20 $ 14.20 $ 120.

844 mil DM . Capital expenditures.613 million DM and capital expenditures of 5. depreciation and working capital are all expected to increase by 5% in 1993.560 mil DM 5.159 mil DM 2.560 million DM in 1992. as a German-based multinational involved in a wide range of businesses. The firm has a beta of 1.306 million DM in 1991 to 15. The valuation of this firm can be done on either a real or a nominal basis: The estimates of growth on a real and nominal basis are done first . 1992 Projected 1993 EBIT (1 . Illustration 13: The Effect of Inflation on Cash flows and Discount Rates Consider a firm which has cash flows to equity currently of $100 million and is expected to grow.613 mil DM 4.5%. in real terms.= Cash flow to the firm Illustration 12: Estimating the expected cash flow to the firm .Siemens Siemens AG. Real cash flows should be discounted at real discount rates.Capital Expenditures 5. at 5% a year for the next three years and 3% a year after that. prior to general provisions and extraordinary charges. The expected inflation rate is 3% in both the firm's cash flows and the general economy. The earnings before interest and taxes is expected to increase to 3. It had depreciation of 4.482 million DM in 1992.Bond rate is 6.tax rate) 2. reported earnings before interest and taxes of 3. In addition. The firm had a tax rate of 38% in 1992.405 million DM in 1992.967 million DM in 1993.Change in Working Capital 1.098 mil DM 770 mil DM Free Cashflow to firm 114 mil DM 696 mil DM INFLATION AND VALUATION Consistency Principle 1: Nominal cash flows should be discounted at nominal discount rates.0 and the current T.838 mil DM . the working capital increased from 14. The free cashflows to the firm for 1992 and 1993 (estimated) are provided below.460 mil DM + Depreciation 4.

08743 = $ 1.078 Terminal value (Nominal Cash flows) = $ 126 * 1.0874 + $ 110 / 1.12/1.271 The terminal values are calculated as follows for real and nominal cash flows: Terminal value (Real Cash flows) = $ 116 * 1.03)-1 = 6. with a historical premium earned by stocks over T.5%) =12% The expected nominal return is estimated using the CAPM.12 + $ 117 / 1..Real Nominal Growth Rate in first 3 years 5% (1.0609 / (.0874 .896 Present value (using nominal cash flows) = $108/1.03 / (.5%.74% E(R) =6.03) = $ 2.Bonds of 5..078) / 1.896 Illustration 13A: The Effect of mismatching cash flows and discount rates Real Cash flows@ Nominal Nominal Cash flows@ Real rate rate .08742 + ($116 + $2.03)(1.09% The discount rate can similarly be estimated on a real and nominal basis: Real Nominal Discount Rate 1.122 + ($126 + $2. The present values of the cash flows to equity and the terminal value can then be calculated using the appropriate discount rate: Present value (using real cash flows) = $105/1.5% +1(5.0609) = $ 2.03)-1 = 8.271) / 1.15% Growth Rate after year 3 3% (1.078 $126 $2.12 . Using these growth rates the cash flows can be generated in both nominal and real terms: Real Cash flows Nominal Cash flows Terminal Nominal Cash Terminal Year CF to Equity Value flows Value 1 $105 $108 2 $110 $117 3 $116 $2.271 This calculation assumes that the growth rates after year 3 are steady state growth rates and will continue through infinity.05)(1.03 -1 = 8.123 = $ 1.

068 The terminal values are miscalculated because cash flows and discount rates are not matched.896 If nominal cash flows are discounted at the real discount rate.293 > True value of $1. Terminal value (using nominal rate and real cash flows) = $ 116 *1.03 / (.03) = $1.325) / 1.12 + $ 110 / 1.068) / 1.207 < True value of $1. E(Rj) = Expected pre-tax return on asset j Rf = Riskfree rate Fj = Beta of asset j . the present value is: Present value (nominal cash flows discounted at real rates) = $108/1.Rf) where.0609) = $ 5.0874 -.12-.122 + ($116 + $1.325 Terminal value (using real rate and nominal cash flows) = $ 126 * 1.325 Nominal Cash flows $108 $117 $126 Terminal Value $5.08742 + ($126 + $5.896 TAXES AND VALUATION Consistency Principle 2: Pre-tax cash flows should be discounted at pre-tax discount rates.068 If real cash flows are discounted at the nominal discount rate.0609 / (. the present value is: Present value (real cash flows discounted at nominal rates) = $105/1.123 = $ 1. After-tax cash flows should be discounted at after-tax discount rates. After-tax version of the Capital Asset Pricing Model E(Rj) = Rf + H+ HFj + H2 (Kj .0874 + $ 117 / 1.08743 = $4.Year CF to Equity 1 2 3 $105 $110 $116 Terminal Value $1.

27 $1.27/1.1293 + $ 2.98/1.15%.91+$93.41 The discount rate can be estimated before personal taxes and used to calculate the present value per share: Discount rate before personal taxes = 7.60 / 1.(Terminal price .Ordinary tax rate) Terminal price after taxes = Terminal price before taxes .93% Present Value per share (based upon pre-tax cash flows and pre-tax discount rates) =$ 2. The firm had a beta of 1.$62.20.($93.43 .05 and the treasury bond rate wass 7.98 $1.41/1.56 3 $2. The following example values Eli Lilly on the basis of cash flows after personal taxes for an investor with a tax rate of 40% for ordinary income and 28% for capital gains.28 = $84.12933 + $3.Initial price) * Capital Gains tax rate = $ 93.41 $2.12934 + ($3.20) * 0.Kj = Dividend Yield of asset j H0 = A constant term H1 = Market premium for systematic risk H2 = Influence of dividend payout on expected returns Illustration 14: Effect of personal taxes on cash flows and discount rates: Eli Lilly The expected dividends and the terminal price were estimated for Eli Lilly at the beginning of 1992 for the next five years (before personal taxes).5%) = 12.91 $93.43 $2.20 The initial price is assumed to be $62.12935 = $ 62.36 2 $2.05 5 $3. The cash flows on a pre and post tax basis are as follows: Before personal taxes After personal taxes Dividends per Terminal Dividends per Terminal Year share price share price 1 $2.35 $84. The cash flows after personal taxes are estimated after personal taxes as follows: Dividends per share after taxes = Dividends per share before taxes * (1 .12932 + $2.79 4 $3.41 The discount rate before personal taxes can be apportioned into dividend yield and price appreciation: .15% + 1.05 (5.45)/1.43 .60 $1.

27 Growth Rate 36.36% 1.40) + 9.90 $0.39% . starting in 1989 and ending in 1994: Year 1989 1990 1991 1992 1993 1994 EPS $0.22% (1 .71% = 9.20 = 3. the following factors have to be considered o how to deal with negative earning o the effect of changing size Illustration 15: Using arithmetic average versus geometric average: Autodesk The following are the earnings per share at Glaxo Pharmaceuticals.35+$84.79/1.56 / 1.0. as long as the discount rates are adjusted accordingly.86% Present Value per share (based upon after-tax cash flows and after-tax discount rates) =$ 1.08865 = $ 62.91 $1.08862 + $1.28) = 8.22% Discount rate after personal taxes = 3. ESTIMATING GROWTH RATES I.3.71% (1 .0886 + $ 1.0.11% 39.93% .05/1.27 / $62.36/1.56% -11.13 $1.02% 12.41)/1.Expected Dividend Yield = 12.27 $1.71% Expected Price Appreciation = Expected Return .66 $0.Expected Dividend Yield = Expected Dividends next year/ Initial Price =$2.08864 + ($2.20 Thus the value is unaffected by whether cash flows are before or after personal taxes. Estimating and Using Historical Growth Rates y y y Historical growth rates can be estimated in a number of different ways o Arithmetic versus Geometric Averages o Simple versus Regression Models Historical growth rates can be sensitive to o the period used in the estimation In using historical growth rates.08863 + $2.

02%+12.66 $0.11%+39..Arithmetic mean = (36.56%-11.39%)/5 = 15.13 $1. The earnings per share from 1988 until 1994 is provided for Glaxo.13 $1.65 $0.27 $1.66)1/5 -1 = 13.66 $0.32% Geometric mean = (1.68% Geometric mean = (1.27/0.24 Linear Regression : EPS = 0.11 -0.91 $1.99% Illustration 16: Sensitivity of historical growth rates to the length of the estimation period: Glaxo The following table provides earnings per share at Glaxo.90 $0.36%+1.90 $0.91 $1.81% Illustration 17: Linear and Log-linear models of growth: Glaxo Inc.12 0. Time (t) 1 2 3 4 5 6 7 Year 1988 1989 1990 1991 1992 1993 1994 EPS $0.65 $0.1132 t . starting in 1988 instead of 1989 and uses six years of growth rather than five to estimate the arithmetic and geometric averages.43 -0.09 0. and the linear and log linear regressions are done below: Time (t) 1 2 3 4 5 6 7 Year 1988 1989 1990 1991 1992 1993 1994 EPS $0.42 -0.27 ln(EPS) -0.5171 + 0.65)1/6 -1 = 11.27 $1.24 0.27/0.27 Arithmetic average = 13.

since the traditional growth rate measures often fail.00/<$1.1225 (8)) = $ 1.1225 t Expected EPS (1995) : linear regression = 0.EPSt-1) Illustration 18: Dealing with negative earnings: Sterling Chemicals. the traditional growth rate measures would be ñ Arithmetic Growth Rate = = EPSt/EPSt-1 -1 = $1.00> .00/<$1.08 -2.00> to $1. For instance.27 2 1989 $1.55% -39.1 = -200 % Geometric growth rate = $1.00.08 129.77 0.07 0.55536 + 0. if earnings per share goes from <$1.06% -88.5536 + 0.00% 7 1994 $0.1132 (8) = $1.Log-linear Regression: ln (EPS) = -0. The following series lists earnings per share from 1988 to 1994 for Sterling Chemicalsñ Growth Modified Time (t) Year EPS log(EPS) Rate Growth Rate 1 1988 $3.00> = -100% There is a solution to this problem.40 -37.57 -50.10) NMF -225.5171 + 0.42 Expected EPS (1995): log-linear regression = e (-0.55% 4 1991 $0. Modified growth rate =(EPSt-EPSt-1)/Max(EPSt.53 -88.41% 440.28% 3 1990 $1.06% 6 1993 ($0.38% 5 1992 $0.00% .28% -50.53 Dealing with negative earnings Calculating growth rates when earnings become negative is problematic.00% 225.07 -39.34 -1.67 -0.56 1.38% -37.

10 Geometric Average Growth Rate = 86.1114 .407.20 1994 $430. % Growth Æ Net Year Net Income Rate Income 1989 $19.30 116.06 = -48.680.0.00 21.42% $4.291.63% $120.Approach 1: Using the slope coefficient from the linear regression EPS =3.40 1993 $354.81% Illustration 19: The Effect of size on growth: Amgen Amgen increased its net income from $19.48% Approach 2: Using the minimum or maximum of earnings as the denominator Arithmetic average.10 1991 $186.51.785.35 1998 $5.5139 / 1.65 II.42% $1.20 351.487.42% Assuming that this growth rate continues for the next five years.31 1999 $9.42% $2.70 64. using modified growth rates = .67 86.0.06 Growth rate = .10 1990 $86. % Growth Æ Net Year Net Income Rate Income 1995 $801.494.32 86.42% $371.16% $75.60 1996 $1.10 1992 $306.1 million in 1989 to $430 million in 1994.60 86. but do not do much better than such models over the long term.42% $692.90 15. in both percentage and dollar terms.31% $67.5139 t Average EPS (1988-94) = $ 1.72 1997 $2.13% $100.72% $48.98 86.192. Analystsí Forecasts Of Earnings: How Good Are They? Studies indicate that analysts do better than mechanical models at forecasting earnings in the short term.63 86. . The following table shows the growth in net income for Amgen from 1989 to 1994.

They are also usually better at picking stocks.8% 1969-79 Are some analysts more equal than others? Some analysts are better at predicting earnings than other analysts.1% 1970-74 Brown & Rozeff Value Line Forecasts 28. 13.2% 1972-75 Fried & Givoly Earnings Forecaster 16.4% 32. For these recommendations the price changes are sustained. Buy recommendations affect prices less than sell recommendations.7% on sells). The prices tend to drift back to their original levels.7% 34. and they continue to rise in the following period (2. Studies examining how effective analysts are conclude the following ñ y y On average. Expected Growth And Fundamentals Retention Ratio and Return on Equity gt = Retained Earningst-1/ NIt-1 * ROE = Retention Ratio * ROE = b * ROE . 4.8% for the sells).Mean Relative Absolute Error Study Analyst Group Analyst Mechanical Forecasts Models Collins & Hopwood Value Line Forecasts 31. analysts affect stock prices with their recommendations. The recommendations made by the ëbestí analysts (Institutional Investorís All American Analysts) have a greater impact on stock prices (3% on buys.4% 19. III.4% for buys.

5% Growth Rate = 0.i (1-t)) .72%. 1994 1995 BV of Equity 11700 Net Income 3010 Retention Ratio 52. Short term changes in ROE Small changes in return on equity can lead to large shifts in the growth rate for some firms. The following table provides information on the retention ratio and the return on equity for Merck for 1994 and projections for 1995.32% A drop in the return on equity of 0.52*0.00% 52% Return on Equity 26. The relationship between growth rates and changes in return on equity is as follows ñ gt = [BV of Equityt-1 * (ROEt .5% translates into a drop in the growth rate of 2.52% + 0.52*0.255 = 11.ROEt-1) / NIt-1]+ b * ROE Illustration 20: Changes in ROE and growth rates: Merck Inc. If the ROE drops by 2% the expected growth rate in 1995 would be 4.255-. ROE and Leverage ROE = ROA + D/E (ROA .26 = (11700*(.20%.0% 25.Proposition 1: The expected growth rate in earnings for a company cannot exceed its return on equity in the long term.26)/3010) = 13.

after-tax profit margin is expected to drop from 7.43% 7. The pre-interest. ROA = (Net Income + Interest (1 . asset turnover and growth rates after the shift in corporate strategy: 1992 After shift in strategy EBIT (1.t) / BV of Total Assets D/E = BV of Debt/ BV of Equity i = Interest Expense on Debt / BV of Debt t = Tax rate on ordinary income Note that BV of Assets = BV of Debt + BV of Equity.424 Asset Turnover 1.6851 to 1.00% Total Assets $17. Return on Assets.80. Profit Margin and Asset Turnover ROA = EBIT (1-t) / Total Assets = [EBIT (1-t) / Sales] * [Sales/Total Assets] = Pre-interest profit margin * Asset Turnover Illustration 22: Evaluating the effects of corporate strategy on growth rate and value: Procter and Gamble Procter & Gamble decided to reduce prices on their disposable diapers in April 1993 to compete better with low-price private label brands.362 Pre-interest.tax rate)) / BV of Total Assets = EBIT (1.tax rate) $ 2181 Sales $ 29.where.80 .43% to 7% as a consequence and the asset turnover is expected to increase from 1.6851 1. The following table provides projections in profit margins. after-tax profit margin 7.

Neutrogena is expected to grow at an extraordinary rate in the first five years (growth phase) and at a stable rate after that (steady state).74% Illustration 23: Adjusting inputs for firm type: Neutrogena Inc. The following table provides estimates of return on assets.00% Debt/Equity 0.91 41.00% 16.89 1988 $1.00% Growth Rate 14.7108 Interest rate on debt (1 .7108 0.Return on Assets 12. The following table also provides analyst forecasts of expected growth over the next five years from nine analysts following Autodesk.00% 10. Consider Autodesk Inc.82% 8.27% Growth Rate 10. retention ratio and interest rates for Neutrogena. Historical EPS Analyst Estimates Growth Year EPS Rate 1987 $0.29% Analyst Number 1 2 3 4 5 6 7 Estimated Growth 10.tax rate) 4.50% 13.00% 58.31 0. a cosmetics manufacturer.a software company.48% 1990 $2.60% Retention Ratio 58.69% 1989 $1.52% 12. with earnings per share available from 1987 to 1992.98 -14.00% 16.5% 15% Debt/Equity 0% 25% Interest rate on debt 10% 8.27% 4.50% 12.35 51.43% 1992 $1.00% 12. Growth phase Steady State Retention Ratio 76% 50% Return on Assets 19.00% .375% Illustration 24: Weighting based upon standard deviations: Autodesk Inc.42% 1991 $2.30 20.66% 10.

45% .00% Arithmetic mean = 19.8 18.49% Standard Deviation = 3.95% Consensus Forecast = 14% Standard Deviation = 27.

placement co's (E)

An investment bank

Report Final

Final Project

Presentation 1

FMCG Sector

- Leia e imprima sem anúncios
- Download to keep your version
- Edit, email or read offline

Are you sure?

This action might not be possible to undo. Are you sure you want to continue?

CANCEL

OK

You've been reading!

NO, THANKS

OK

scribd

/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->